<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               ADVERSE REACTIONS<BR>               The following adverse events were observed and have been reported in patients using propranolol.<BR><BR>                  <BR><BR>                  Cardiovascular:<BR><BR>                  Bradycardia; congestive heart failure; intensification of AV block; hypotension; parasthesia of hands; thrombocytopenic purpura; arterial insufficiency, usually of the Raynaud type.<BR><BR>                  <BR><BR>                  Central Nervous System:<BR>Light-headedness; mental depression manifested by insomnia, lassitude, weakness, fatigue; catatonia; visual disturbances; hallucinations; vivid dreams; an acute reversible syndrome characterized by disorientation for time and place, short-term memory loss, emotional lability, slightly clouded sensorium, and decreased performance on neuropsychometrics. For immediate release formulations, fatigue, lethargy, and vivid dreams appear dose related.<BR>                  <BR><BR>                  <BR><BR>                  Gastrointestinal:<BR><BR>                  Nausea, vomiting, epigastric distress, abdominal cramping, diarrhea, constipation, mesenteric arterial thrombosis, ischemic colitis.<BR><BR>                  <BR><BR>                  Allergic:<BR><BR>                  Hypersensitivity reactions, including anaphylactic/ anaphylactoid reactions; pharyngitis and agranulocytosis; erythematous rash; fever combined with aching and sore throat; laryngospasm; respiratory distress. <BR><BR>                  <BR><BR>                  Respiratory:<BR><BR>                  Bronchospasm.<BR><BR>                  <BR><BR>                  Hematologic:<BR><BR>                  Agranulocytosis, nonthrombocytopenic purpura, and thrombocytopenic purpura.<BR><BR>                  <BR><BR>                  Autoimmune:<BR><BR>                  Systemic lupus erythematosus (SLE).<BR><BR>                  <BR><BR>                  Skin and mucous membranes:<BR><BR>                  Stevens-Johnson Syndrome, toxic epidermal necrolysis, dry eyes, exfoliative dermatitis, erythema multiforme, urticaria, alopecia, SLE-like reactions, and psoriasisiform rashes. Oculomucocutaneous syndrome involving the skin, serous membranes, and conjunctivae reported for a beta-blocker (practolol) have not been associated with propranolol.<BR><BR>                  <BR><BR>                  Genitourinary:<BR><BR>                  Male impotence; Peyronie's disease.<BR><BR>                  <BR><BR>               <BR>               <BR>            <BR>         </P></DIV></HTML>